🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Miro Sciences Ltd (ASX:MSX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0430
0.00 (0.00%)
Nov 19, 2026, 2:59 PM AEDT

Miro Sciences Company Description

Miro Sciences Ltd engages in the research and development of biomedical products targeting neurodegenerative conditions and immune-mediated inflammatory diseases.

Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders.

Miro Sciences Ltd was formerly known NeuroScientific Biopharmaceuticals Limited and change its name to Miro Sciences Ltd in October 2026.

The company was incorporated in 2002 and is based in Perth, Australia.

Miro Sciences Ltd
CountryAustralia
Founded2002
IndustryBiotechnology
SectorHealthcare
CEONathan Smith

Contact Details

Address:
Level 4
Perth, Washington 6000
Australia
Phone61 8 6268 2641
Websitemirosciences.com

Stock Details

Ticker SymbolMSX
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000496887
SIC Code2836

Key Executives

NamePosition
Nathan SmithChief Executive Officer
Dr. Marian SturmChief Scientific Officer
Dr. Catherine Cole MBBSChief Medical Officer
Chris KneeChief Financial Officer
Christopher Bryan James Achurch B.Com., C.A.Company Secretary